期刊文献+

激素替代疗法治疗围绝经期综合征妇女血E2、FSH水平的影响研究 被引量:3

Effect Study on Female Patients' Blood E2, FSH Levels with Treatment of Hormone Replacement Therapy to Perimenopausal Syndrome
下载PDF
导出
摘要 目的探讨激素替代疗法治疗围绝经期综合征妇女的疗效及对血雌二醇(E2)、卵泡刺激素(FSH)水平的影响。方法随机选取2013年5月—2015年1月该院收治的110例围绝经期综合征妇女作为研究对象,采用随机数字表法将所选患者分为研究组和对照组,每组各55例,研究组给予激素替代疗法治疗,对照组给予常规对症治疗。综合比较两组患者治疗总有效率、治疗前后血清E2、FSH变化情况及不良反应。结果研究组治疗总有效率为94.5%,高于对照组的80.0%(P<0.05);治疗后研究组患者血清E2水平升高,FSH水平降低,改善程度优于对照组(P<0.05);两组患者均无严重不良反应发生,耐受性好。结论激素替代疗法治疗围绝经期综合征妇女效果确切,安全性高,可显著改善患者的血E2、FSH水平。 Objective To investigate the effect of hormone replacement therapy for climacteric syndrome and the influence on blood E2,FSH level. Methods 110 cases of climacteric syndrome in our hospital, were randomly divided into research group and control group, each with 55 cases. Research group were treated with hormone replacement therapy. Control group were treated with conventional symptomatic treatment. Total effective rate, serum E2,FSH changes before and after treatment and adverse reactions were compared. Results Total effective rate of research group was 94.5%,which was higher than 80.0% of control group(P〈0.05).After treatment, serum E2 levels of research group elevated, FSH levels declined, the degree of improvement were better than the control group(P〈0.05). Both of two groups had no serious adverse reactions. Conclusion Hormone replacement therapy for climacteric syndrome is effective and safety. It could significantly improve level of serum E2, FSH.
出处 《中外医疗》 2015年第22期138-139,共2页 China & Foreign Medical Treatment
关键词 激素替代 围绝经期综合征 临床疗效 Hormone replacement therapy Climacteric syndrome Clinical efficacy
  • 相关文献

参考文献8

二级参考文献46

  • 1高娜,石红.围绝经期症状与激素替代治疗进展[J].大连医科大学学报,2009,31(1):98-101. 被引量:19
  • 2曹泽毅.中华妇产科学.2版.北京:人民卫生出版社,2005:844-845.
  • 3韩悦,谢惠莲,张自玲,赵友芬,夏学敏.中西医结合治疗围绝经期综合征患者临床疗效观察[J].中国医药导报,2007,4(08X):86-88. 被引量:7
  • 4朱文锋.中医主症鉴别诊断学[M].长沙:湖南科技出版社,2000.316-331.
  • 5乐杰.妇产科学[M].6版.北京:人民卫生出版社,2003:55-58
  • 6Ho SC, Chan SG, Yip YB et al. Change in bone mineral densi- ty and its determinants in pre - and perimenopausal chinese women: the Hong Kong perimenopausal women osteoporosis study [J].Osteoporos Int, 2008, 19 (12) : 1785.
  • 7Tarkkila L, Furuholm J, Tiitinen A et al. Oral health in perim- enopausal and early postmenopausal women from baseline to 2 years of follow - up with reference to hormone replacement ther- apy [J]. Clin Oral Invest, 2008, 12 (3) : 271.
  • 8Collins P, Rosano G, Casey C et al. Management of cardiovas- cular risk in the perimenopausal women: a consensus statement of European cardiologists and gynecologists [ J]. Climacteric, 2007, 10 (6): 508.
  • 9Stefanick ML, Anderson GL, Margolis KL et al. Effects of con- jugated equine estrogens on breast cancer and mammographyscreening in postmenopausal women with hysterectomy [J]. JAMA. 2006. 295 (14): 1647.
  • 10Kailas NA, Sifakis S, Koumantakis E, et al. Contracep-tion during peri-menopause[J]. Eur J Contracept Reprod Health Care, 2005,10(1):19.

共引文献138

同被引文献45

引证文献3

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部